T1	CHEM 62 87	Aceite enriquecido en CBD
T2	PROC 94 105	tratamiento
#1	AnnotatorNotes T2	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T3	DISO 153 181	complejo esclerosis tuberosa
T4	DISO 183 186	CET
T5	DISO 210 229	Esclerosis tuberosa
#2	AnnotatorNotes T5	C0041341; Tuberous Sclerosis; Neoplastic Process
T6	DISO 234 243	epilepsia
#3	AnnotatorNotes T6	C0014544; Epilepsy; Disease or Syndrome
T7	DISO 312 343	Complejo de Esclerosis Tuberosa
T8	PROC 372 383	Diagnóstico
#4	AnnotatorNotes T8	C0011900; Diagnosis; Diagnostic Procedure
T9	DISO 398 401	CET
T10	PROC 430 446	estudio genético
T11	DISO 485 488	CET
T12	Neg_cue 516 518	no
T13	Negated 519 540	responde exitosamente
T14	CHEM 543 547	FAEs
T15	PROC 573 589	dieta cetogénica
T16	DEVI 591 618	estimulador del nervio vago
T17	Neg_cue 624 626	no
T18	PROC 645 668	cirugía de la epilepsia
T19	DISO 685 691	crisis
#5	AnnotatorNotes T19	C0036572; Seizures; Sign or Symptom | C0231224; Crisis; Finding
T20	PROC 712 735	intervención quirúrgica
#6	AnnotatorNotes T20	C0543467; Operative Surgical Procedures; Therapeutic or Preventive Procedure
T21	DISO 763 769	crisis
#7	AnnotatorNotes T21	C0036572; Seizures; Sign or Symptom | C0231224; Crisis; Finding
T22	Frequency 776 790	4 o más al mes
T23	DISO 795 801	signos
#8	AnnotatorNotes T23	C0311392; Physical findings; Finding
T24	DISO 824 845	pérdida de conciencia
#9	AnnotatorNotes T24	C0041657; Unconscious State; Finding
T25	CHEM 895 899	FAEs
T26	Duration 903 916	las 4 semanas
T27	PROC 930 942	intervención
#10	AnnotatorNotes T27	C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T28	CHEM 950 979	aceite enriquecido en CBD+THC
T29	PROC 983 999	dieta cetogénica
T30	DEVI 1017 1028	dispositivo
#11	AnnotatorNotes T30	C1285539; Direct device; Medical Device
T31	DEVI 1041 1068	estimulador del nervio vago
T32	Neg_cue 1069 1072	sin
T33	Negated 1073 1080	cambios
T34	CHEM 1105 1113	fármacos
#12	AnnotatorNotes T34	C0013227; Pharmaceutical Preparations; Pharmacologic Substance
T35	PROC 1144 1158	ensayo clínico
#13	AnnotatorNotes T35	C0008976; Clinical Trials; Research Activity
T36	LIVB 1194 1204	cuidadores
#14	AnnotatorNotes T36	C0085537; Caregiver; Professional or Occupational Group | C1305660; Carer (occupation); Professional or Occupational Group
T37	LIVB 1304 1313	Pacientes
#15	AnnotatorNotes T37	C0030705; Patients; Patient or Disabled Group
T38	PROC 1318 1329	diagnóstico
#16	AnnotatorNotes T38	C0011900; Diagnosis; Diagnostic Procedure
T39	Neg_cue 1330 1332	no
T40	Negated 1333 1343	confirmado
T41	CHEM 1357 1368	corticoides
#17	AnnotatorNotes T41	C0001617; Adrenal Cortex Hormones; Hormone · Organic Chemical · Pharmacologic Substance
T42	Neg_cue 1374 1376	no
T43	Negated 1377 1418	pasaron por las alternativas terapéuticas
T44	Neg_cue 1429 1431	no
T45	Negated 1432 1456	adhirieron correctamente
T46	CHEM 1463 1467	FAEs
T47	DISO 1507 1559	Insuficiencia cardíaca, renal, hepática, pancreática
T48	DISO 1563 1586	disfunción hematológica
T49	PROC 1629 1639	creatinina
#18	AnnotatorNotes T49	C0201975; Creatinine measurement; Laboratory Procedure
T50	PROC 1642 1646	urea
#19	AnnotatorNotes T50	C0523961; Urea measurement; Laboratory Procedure
T51	PROC 1684 1697	transaminasas
#20	AnnotatorNotes T51	C0919834; Transaminase Assay; Laboratory Procedure
T52	PROC 1699 1705	lipasa
#21	AnnotatorNotes T52	C0373670; Lipase measurement; Laboratory Procedure
T53	PROC 1708 1722	amilasa sérica
#22	AnnotatorNotes T53	C0201885; Amylase measurement, serum (procedure); Laboratory Procedure
T54	PROC 1724 1733	plaquetas
T55	PROC 1749 1777	recuento de glóbulos blancos
T56	DISO 1791 1807	Condición médica
#23	AnnotatorNotes T56	C4745084; Medical Condition; Finding
T57	Neg_cue 1815 1817	no
T58	Negated 1818 1828	controlada
T59	DISO 1835 1854	enfermedad hepática
#24	AnnotatorNotes T59	C0023895; Liver diseases; Disease or Syndrome
T60	DISO 1856 1864	cirrosis
#25	AnnotatorNotes T60	C1623038; Cirrhosis; Disease or Syndrome
T61	DISO 1866 1900	hepatitis crónica (hepatitis B o C
T62	DISO 1903 1911	diabetes
#26	AnnotatorNotes T62	C0011849; Diabetes Mellitus; Disease or Syndrome
T63	Neg_cue 1912 1914	no
T64	Negated 1915 1925	controlada
T65	PROC 1941 1955	glucosa sérica
#27	AnnotatorNotes T65	C0202041; Glucose measurement, serum; Laboratory Procedure
T66	DISO 1967 1978	infecciones
#28	AnnotatorNotes T66	C0009450; Communicable Diseases; Disease or Syndrome | C3714514; Infection; Pathologic Function
T67	DISO 2009 2020	infecciones
#29	AnnotatorNotes T67	C0009450; Communicable Diseases; Disease or Syndrome | C3714514; Infection; Pathologic Function
T68	Neg_cue 2029 2031	no
T69	Negated 2032 2043	controladas
T70	DISO 2045 2054	sangrados
#30	AnnotatorNotes T70	C0019080; Hemorrhage; Pathologic Function
T71	LIVB 2066 2075	Pacientes
#31	AnnotatorNotes T71	C0030705; Patients; Patient or Disabled Group
T72	LIVB 2082 2090	familias
#32	AnnotatorNotes T72	C0015576; Family; Family Group
T73	Neg_cue 2091 2093	no
T74	Negated 2104 2144	cumplir con los requerimientos y visitas
T75	PROC 2137 2144	visitas
T76	Spec_cue 2206 2215	riesgo de
T77	Speculated 2216 2244	incumplimiento del protocolo
T78	PROC 2235 2244	protocolo
#33	AnnotatorNotes T78	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T79	DISO 2248 2255	Alergia
#34	AnnotatorNotes T79	C0020517; Hypersensitivity; Pathologic Function
T80	CHEM 2288 2306	aceite de cannabis
T81	DISO 2337 2350	esquizofrenia
#35	AnnotatorNotes T81	C0036341; Schizophrenia; Mental or Behavioral Dysfunction
T82	DISO 2380 2399	intento de suicidio
#36	AnnotatorNotes T82	C0038663; Suicide attempt; Injury or Poisoning | C0582496; Suicidal intent; Finding
T83	LIVB 2403 2412	Pacientes
#37	AnnotatorNotes T83	C0030705; Patients; Patient or Disabled Group
T84	PROC 2417 2440	cambiaron la medicación
T85	CHEM 2452 2456	FAEs
T86	PROC 2509 2525	dieta cetogenica
T87	DEVI 2528 2545	estimulador vagal
T88	PHYS 2548 2556	Embarazo
#38	AnnotatorNotes T88	C0032961; Pregnancy; Organism Function
T89	Negated 645 668	cirugía de la epilepsia
T90	Duration 1988 1996	crónicas
T91	Duration 1999 2005	agudas
T92	PROC 407 425	criterios clínicos
T93	LIVB 2175 2181	médico
T94	Duration 2465 2476	los 30 días
T95	DISO 109 118	epilepsia
T96	DISO 450 459	Epilepsia
T97	DISO 287 296	Epilepsia
T98	Observation 247 262	difícil control
T99	Observation 519 540	responde exitosamente
T100	Quantifier_or_Qualifier 563 570	2 o más
T101	CONC 1073 1080	cambios
T102	Quantifier_or_Qualifier 1083 1085	Un
T103	Quantifier_or_Qualifier 1086 1104	número máximo de 3
T104	Quantifier_or_Qualifier 1114 1127	concomitantes
T105	CONC 1131 1158	comienzo del ensayo clínico
T106	CONC 1222 1238	diario de crisis
T107	CONC 1252 1261	inclusión
T108	CONC 1393 1405	alternativas
T109	Observation 1432 1456	adhirieron correctamente
T110	Result_or_Value 1591 1625	valores sobre los límites normales
T111	Result_or_Value 1648 1655	valores
T112	Result_or_Value 1656 1680	2 veces el límite normal
T113	Result_or_Value 1734 1745	< 80000/mm3
T114	Result_or_Value 1778 1787	<3000/mm3
T115	Quantifier_or_Qualifier 1808 1814	severa
T116	Quantifier_or_Qualifier 1818 1828	controlada
T117	Quantifier_or_Qualifier 1915 1925	controlada
T118	Result_or_Value 1956 1963	>150 mg
T119	Quantifier_or_Qualifier 1979 1986	activas
T120	Quantifier_or_Qualifier 1988 1996	crónicas
T121	Quantifier_or_Qualifier 1999 2005	agudas
T122	Quantifier_or_Qualifier 2021 2028	severas
T123	Quantifier_or_Qualifier 2032 2043	controladas
T124	Quantifier_or_Qualifier 2055 2062	activos
T125	Observation 2201 2215	alto riesgo de
T126	Observation 2216 2244	incumplimiento del protocolo
T127	CONC 2488 2506	inicio del estudio
T128	Other 1194 1204	cuidadores
T129	Patient 1304 1313	Pacientes
T130	Patient 2066 2075	Pacientes
T131	Family_member 2082 2090	familias
T132	Other 2175 2190	médico tratante
T133	History_of 2248 2255	Alergia
T134	History_of 2337 2350	esquizofrenia
T135	History_of 2380 2399	intento de suicidio
T136	Patient 2403 2412	Pacientes
